{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Liver Transplantation for Wilson disease: Current Knowledge and Future Perspectives

Activity Steps

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Describe the pathophysiology and hepatic and neuropsychiatric features that characterize Wilson disease and its clinical phenotypes.
  2. Discuss how to apply medical therapy for the treatment of Wilson disease prior to end-stage liver disease and need for liver transplantation.
  3. Identify the indications for liver transplantation for Wilson disease, including in those with nonhepatic clinical phenotypes of disease.
Price: $30.00

Credits:

  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: LVT1224B
Published: December 2024
Expires: 11/30/2026
Required Passing Score: 4/5 (80%)
Authors: Alberto Ferrarese, Nora Cazzagon, and Patrizia Burra
Categories: Hepatology
Specialties: Hepatology